Bangkok, 29 November 2006 - the Royal Thai Government today announced that it would issue a government use licence to improve access to Efavirenz, a key HIV/AIDS medicine. Efavirenz is currently patent protected in Thailand , and the resulting monopolistic situation is limiting supply and affordability.
11/30/2006 - 01:00
Subscribe to HIV

ประชาธรรม บน เฟสบุ๊ก